Table 3:

Number and percentage distribution of cochlear and vestibular EH grading by 2 pulse sequences in 50 patients with MD

3D ZOOMit SPACE Real IR3D TSE Real IRWilcoxon Signed-Rank Test
(No.) (%)(No.) (%)Z ValueP Value
Affected side
 No cochlear EH7 (14.0)a15 (30.0)–2.83.005
 Cochlear EH (I)12 (24.0)a4 (8.0)
 Cochlear EH (II)31 (62.0)31 (62.0)
 No vestibular EH3 (6.0)3 (6.0)0.001.000
 Vestibular EH (I)13 (26.0)13 (26.0)
 Vestibular EH (II)18 (36.0)18 (36.0)
 Vestibular EH (III)16 (32.0)16 (32.0)
Asymptomatic side
 No cochlear EH46 (92.0)48 (96.0)–1.41.157
 Cochlear EH (I)3 (6.0)1 (2.0)
 Cochlear EH (II)1 (2.0)1 (2.0)
 No vestibular EH48 (96.0)48 (96.0)0.001.000
 Vestibular EH (I)0 (0.0)0 (0.0)
 Vestibular EH (II)2 (4.0)2 (4.0)
 Vestibular EH (III)0 (0.0)0 (0.0)
  • a Compared with the 3D TSE real IR sequence, P < .017.